Meridian Bioscience reported $31.68M in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbott ABT:US USD 4.59B 36M
Accelerate Diagnostics AXDX:US USD 2.19M 591K
Atrion ATRI:US USD 28.05M 5.13M
Becton, Dickinson and BDX:US USD 2.68B 111M
Bio Rad Laboratories BIO:US USD 305.71M 10.59M
Cerus CERS:US USD 17.66M 2.06M
Meridian Bioscience VIVO:US USD 31.68M 640K
Myriad Genetics MYGN:US USD 50.4M 700K
Neogen NEOG:US USD 117.49M 47.42M
Orasure Technologies OSUR:US USD 70.27M 17.62M
Rockwell Medical RMTI:US USD 17.91M 977K
Sientra SIEN:US USD 9.79M 1.02M
Staar Surgical STAA:US USD 15.58M 1.64M
Thermo Fisher Scientific TMO:US USD 6.25B 125M